Overview

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Status:
Completed

Trial end date:
2004-08-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients with metastatic or locally advanced bladder cancer.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Collaborator:

National Cancer Institute (NCI)

Treatments:

Albumin-Bound Paclitaxel
Cisplatin
Doxorubicin
Gemcitabine
Ifosfamide
Isophosphamide mustard
Liposomal doxorubicin
Paclitaxel